224 related articles for article (PubMed ID: 33744687)
21. A next-generation bifunctional photosensitizer with improved water-solubility for photodynamic therapy and diagnosis.
Nishie H; Kataoka H; Yano S; Kikuchi JI; Hayashi N; Narumi A; Nomoto A; Kubota E; Joh T
Oncotarget; 2016 Nov; 7(45):74259-74268. PubMed ID: 27708235
[TBL] [Abstract][Full Text] [Related]
22. Design, synthesis and biological evaluation of novel thioquinazolinone-based 2-aminobenzamide derivatives as potent histone deacetylase (HDAC) inhibitors.
Cheng C; Yun F; He J; Ullah S; Yuan Q
Eur J Med Chem; 2019 Jul; 173():185-202. PubMed ID: 31003060
[TBL] [Abstract][Full Text] [Related]
23. Anticancer effects of novel photodynamic therapy with glycoconjugated chlorin for gastric and colon cancer.
Tanaka M; Kataoka H; Mabuchi M; Sakuma S; Takahashi S; Tujii R; Akashi H; Ohi H; Yano S; Morita A; Joh T
Anticancer Res; 2011 Mar; 31(3):763-9. PubMed ID: 21498693
[TBL] [Abstract][Full Text] [Related]
24. Palladium porphyrin complexes for photodynamic cancer therapy: effect of porphyrin units and metal.
Deng J; Li H; Yang M; Wu F
Photochem Photobiol Sci; 2020 Jul; 19(7):905-912. PubMed ID: 32369050
[TBL] [Abstract][Full Text] [Related]
25. Porphyrin and phthalocyanine photosensitizers designed for targeted photodynamic therapy of colorectal cancer.
Janas K; Boniewska-Bernacka E; Dyrda G; Słota R
Bioorg Med Chem; 2021 Jan; 30():115926. PubMed ID: 33341498
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and preliminary bioactivity studies of 1,3,4-thiadiazole hydroxamic acid derivatives as novel histone deacetylase inhibitors.
Guan P; Sun F; Hou X; Wang F; Yi F; Xu W; Fang H
Bioorg Med Chem; 2012 Jun; 20(12):3865-72. PubMed ID: 22579621
[TBL] [Abstract][Full Text] [Related]
27. Design, Synthesis and Biological Evaluation of Novel Benzoylimidazole Derivatives as Raf and Histone Deacetylases Dual Inhibitors.
Chen X; Gong G; Chen X; Song R; Duan M; Qiao R; Jiao Y; Qi J; Chen Y; Zhu Y
Chem Pharm Bull (Tokyo); 2019; 67(10):1116-1122. PubMed ID: 31582631
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of novel chlorophyll a derivatives as potent photosensitizers for photodynamic therapy.
Gao YH; Zhu XX; Zhu W; Wu D; Chen DY; Yan YJ; Wu XF; O'Shea DF; Chen ZL
Eur J Med Chem; 2020 Feb; 187():111959. PubMed ID: 31846830
[TBL] [Abstract][Full Text] [Related]
29. An epidermal growth factor receptor-targeted and endoplasmic reticulum-localized organic photosensitizer toward photodynamic anticancer therapy.
Zhao X; Ma H; Chen J; Zhang F; Jia X; Xue J
Eur J Med Chem; 2019 Nov; 182():111625. PubMed ID: 31442683
[TBL] [Abstract][Full Text] [Related]
30. Development of Purine-Based Hydroxamic Acid Derivatives: Potent Histone Deacetylase Inhibitors with Marked in Vitro and in Vivo Antitumor Activities.
Chen Y; Wang X; Xiang W; He L; Tang M; Wang F; Wang T; Yang Z; Yi Y; Wang H; Niu T; Zheng L; Lei L; Li X; Song H; Chen L
J Med Chem; 2016 Jun; 59(11):5488-504. PubMed ID: 27186676
[TBL] [Abstract][Full Text] [Related]
31. Anti-tumor activity evaluation of novel tubulin and HDAC dual-targeting inhibitors.
Wang B; Chen X; Gao J; Su L; Zhang L; Xu H; Luan Y
Bioorg Med Chem Lett; 2019 Sep; 29(18):2638-2645. PubMed ID: 31400938
[TBL] [Abstract][Full Text] [Related]
32. Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity.
Hieu DT; Anh DT; Hai PT; Huong LT; Park EJ; Choi JE; Kang JS; Dung PTP; Han SB; Nam NH
Chem Biodivers; 2018 Jun; 15(6):e1800027. PubMed ID: 29667768
[TBL] [Abstract][Full Text] [Related]
33. Synthesis, Photophysical Properties and Application of New Porphyrin Derivatives for Use in Photodynamic Therapy and Cell Imaging.
Mahajan PG; Dige NC; Vanjare BD; Phull AR; Kim SJ; Hong SK; Lee KH
J Fluoresc; 2018 Jul; 28(4):871-882. PubMed ID: 30014275
[TBL] [Abstract][Full Text] [Related]
34. Design, synthesis and biological evaluation of novel 2-aminobenzamides containing dithiocarbamate moiety as histone deacetylase inhibitors and potent antitumor agents.
Xie R; Li Y; Tang P; Yuan Q
Eur J Med Chem; 2018 Jan; 143():320-333. PubMed ID: 29202397
[TBL] [Abstract][Full Text] [Related]
35. Novel chlorin e
Huang F; Li Y; Zhang XJ; Lin MY; Han GY; Lin HY; Lin HY; Miao Z; Li BH; Sheng CQ; Yao JZ
Eur J Med Chem; 2023 Dec; 261():115787. PubMed ID: 37690263
[TBL] [Abstract][Full Text] [Related]
36. Development of 3-hydroxycinnamamide-based HDAC inhibitors with potent in vitro and in vivo anti-tumor activity.
Li X; Hou J; Li X; Jiang Y; Liu X; Mu W; Jin Y; Zhang Y; Xu W
Eur J Med Chem; 2015 Jan; 89():628-37. PubMed ID: 25462271
[TBL] [Abstract][Full Text] [Related]
37. Design, synthesis and antitumor activity evaluation of novel HDAC inhibitors with tetrahydrobenzothiazole as the skeleton.
Sun S; Zhao W; Li Y; Chi Z; Fang X; Wang Q; Han Z; Luan Y
Bioorg Chem; 2021 Mar; 108():104652. PubMed ID: 33497873
[TBL] [Abstract][Full Text] [Related]
38. Surface Decorated Porphyrinic Nanoscale Metal-Organic Framework for Photodynamic Therapy.
Kan JL; Jiang Y; Xue A; Yu YH; Wang Q; Zhou Y; Dong YB
Inorg Chem; 2018 May; 57(9):5420-5428. PubMed ID: 29664624
[TBL] [Abstract][Full Text] [Related]
39. Studies on preparation and photodynamic mechanism of chlorin P6-13,15-N-(cyclohexyl)cycloimide (Chlorin-H) and its antitumor effect for photodynamic therapy in vitro and in vivo.
Yan YJ; Zheng MZ; Chen ZL; Yu XH; Yang XX; Ding ZL; Xu L
Bioorg Med Chem; 2010 Sep; 18(17):6282-91. PubMed ID: 20691601
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of 17
Zhu W; Wang LX; Chen DY; Gao YH; Yan YJ; Wu XF; Wang M; Han YP; Chen ZL
Bioorg Med Chem Lett; 2018 Sep; 28(16):2784-2788. PubMed ID: 29279274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
